[Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia]

Yukiko Hayashi1

  • 1Department of Neurophysiology, Tokyo Medical University.

Insights

Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia (IBMPFD), caused by VCP gene mutations, presents with variable muscle weakness, bone disease, and dementia. Diagnosis can be challenging due to complex clinical findings.

Area of Science:

  • Genetics
  • Neurology
  • Pathology

Background:

  • Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia (IBMPFD) is an autosomal dominant disorder.
  • Mutations in the VCP gene cause IBMPFD, affecting the valosin-containing protein (VCP) involved in cellular processes.
  • VCP plays critical roles in protein quality control, protein aggregation, mitochondrial function, and cell proliferation.

Purpose of the Study:

  • To summarize the clinical and pathological features of IBMPFD.
  • To highlight the diagnostic challenges associated with this rare disease.

Main Methods:

  • Review of clinical data and pathological findings in patients with IBMPFD.
  • Analysis of the role of VCP gene mutations in disease pathogenesis.

Main Results:

  • Muscle weakness is the most common symptom, with onset around age 40.
  • Pathology reveals cytoplasmic/nuclear inclusions, rimmed vacuoles, and myofibrillar disorganization.
  • Paget's disease of bone affects about half of patients, while frontotemporal dementia occurs in one-third, typically later.

Conclusions:

  • IBMPFD is caused by VCP gene mutations and presents with a spectrum of symptoms including myopathy, bone disease, and dementia.
  • The disease is not as rare as previously thought, but its varied presentation complicates diagnosis.
  • Recognizing the diverse clinical manifestations is crucial for accurate and timely diagnosis.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
166
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
36
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K